Skip to content

The Effectiveness of Telerehabilitation in Improving Upper Extremity in Parkinson's Patients

The Effectiveness of Task-Oriented Training Based Telerehabilitation in Improving Upper Extremity Motor Function in Parkinson's Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04835649
Enrollment
30
Registered
2021-04-08
Start date
2021-04-15
Completion date
2022-05-25
Last updated
2022-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson Disease, Telerehabilitation, Task-oriented, upper extremity

Brief summary

Parkinson's Disease (PD) is a disease that affects the functional skills of the upper extremity with clinical findings such as bradykinesia, rigidity, and hypokinesia and causes limitations in the daily life activities of the patients. Task-oriented training (TOT) is a highly individualized, client-centered, occupational therapy, functional-based intervention compatible with motor learning and motor control principles such as intensive motor training, variable practice, and intermittent feedback. Few studies have been found on the TOT of the upper extremity in PD. Telerehabilitation of Parkinson's patients shows many strengths, such as cost-related and time-dependent ease, and the possibility of telecommunication with clinicians. In addition, the refinement of digital health solutions with the goal to offer a patient-tailored intervention remains an ongoing process. There are a limited number of studies on TOT and telerehabilitation of the upper extremity in PD. In addition, no studies have been found applying TOT through telerehabilitation. For this purpose, a study including TOT-based telerehabilitation in upper extremity education in PD was planned.

Detailed description

This study is a randomized controlled study. The patients will be randomly divided into two groups as exercise and control. Balance and walking exercises consisting of 3 days a week for 6 weeks will be given to both groups as a home program. In addition, the exercise group will receive TOT-based telerehabilitation via video conferencing 3 days a week for 6 weeks. TOT will be formed from daily life activities such as reaching out, grasping, writing, and manual skills, which are frequently used in daily life. As the outcome measures, disease severity and disability, finger and hand function, hand strength, and quality of life will be evaluated.

Interventions

OTHERExercise

Both groups will receive exercise-based training

Sponsors

Gazi University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Two groups as exercise group and control group

Eligibility

Sex/Gender
ALL
Age
45 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 45- 70 years of age * Having diagnosed with Parkinson's Disease by a specialist physician * Having between 1-3 stages according to the Hoehn and Yahr Scale * Mini-Mental Test score more than or equal 24

Exclusion criteria

\- Any orthopedic, vision, hearing, cardiovascular, or perception problems that may affect the research results

Design outcomes

Primary

MeasureTime frameDescription
Manual dexterity performance - BaselineAssessment will be conducted before the interventionNine Hole Peg test (9-HPT)
Manual dexterity performance - Post interventionAssessment will be conducted immediately after the interventionNine Hole Peg test (9-HPT)
Finger and hand function - BaselineAssessment will be conducted before the interventionJebsen-Taylor Hand Function Test (JTHFT)
Finger and hand function - Post interventionAssessment will be conducted immediately after the interventionJebsen-Taylor Hand Function Test (JTHFT)
Upper extremity performance (coordination, dexterity and functioning) - BaselineAssessment will be conducted before the interventionAction Research Arm Test (ARAT)
Upper extremity performance (coordination, dexterity and functioning) - Post interventionAssessment will be conducted immediately after the interventionAction Research Arm Test (ARAT)

Secondary

MeasureTime frameDescription
Health-related Quality of Life - BaselineAssessment will be conducted before the interventionParkinson's Disease Questionnaire 8 (PDQ-8). There are 8 questions in total and each question is scored from 0-4 points. High score indicates decreased quality of life
Isometric hand strength - BaselineAssessment will be conducted before the interventionJ-Tech ™
Health-related Quality of Life - Post interventionAssessment will be conducted immediately after the interventionParkinson's Disease Questionnaire 8 (PDQ-8). There are 8 questions in total and each question is scored from 0-4 points. High score indicates decreased quality of life
Isometric hand strength - Post interventionAssessment will be conducted immediately after the interventionJ-Tech ™
Isometric pinch strength - BaselineAssessment will be conducted before the interventionBaseline® pinch meter
Isometric pinch strength - Post interventionAssessment will be conducted immediately after the interventionBaseline® pinch meter
Disease severity and disability - BaselineAssessment will be conducted before the interventionMDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UPDRS has a maximum score of 272 and is composed of four parts: Part I (non-motor experiences of daily living), Part II (motor experiences of daily living), Part III (motor examination) and Part IV (motor complications) (UPDRS). (0= best , 272= worst)
Disease severity and disability - Post interventionAssessment will be conducted immediately after the interventionMDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UPDRS has a maximum score of 272 and is composed of four parts: Part I (non-motor experiences of daily living), Part II (motor experiences of daily living), Part III (motor examination) and Part IV (motor complications) (UPDRS). (0= best , 272= worst)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026